Trademark: 90301364
Word
ADC THERAPEUTICS
Status
Pending
Status Code
732
Status Date
Monday, February 26, 2024
Serial Number
90301364
Mark Type
3000
Filing Date
Thursday, November 5, 2020
Published for Opposition
Tuesday, May 24, 2022

Trademark Owner History
ADC Therapeutics SA - Owner At Publication

Classifications
5 Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, autoimmune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
The mark consists of the letters "ADC" above the word "THERAPEUTICS". A wave element extends across the letter "A" to a shared edge of the letters "D" and "C".
"THERAPEUTICS"

Trademark Events
Feb 27, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 27, 2024
Corrected Noa E-Mailed
Feb 26, 2024
Sou Extension 3 Granted
Jan 18, 2024
Sou Extension 3 Filed
Feb 26, 2024
Divisional Processing Complete
Jan 18, 2024
Divisional Request Received
Feb 5, 2024
Case Assigned To Intent To Use Paralegal
Jan 18, 2024
Teas Request To Divide Received
Jan 18, 2024
Sou Teas Extension Received
Jul 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2023
Sou Extension 2 Granted
Jul 13, 2023
Sou Extension 2 Filed
Jul 13, 2023
Sou Teas Extension Received
Jan 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 18, 2023
Sou Extension 1 Granted
Jan 18, 2023
Sou Extension 1 Filed
Jan 18, 2023
Sou Teas Extension Received
Jul 19, 2022
Noa E-Mailed - Sou Required From Applicant
May 24, 2022
Official Gazette Publication Confirmation E-Mailed
May 24, 2022
Published For Opposition
May 4, 2022
Notification Of Notice Of Publication E-Mailed
Apr 20, 2022
Exparte Appeal Terminated
Apr 20, 2022
Approved For Pub - Principal Register
Apr 13, 2022
Teas/Email Correspondence Entered
Apr 13, 2022
Correspondence Received In Law Office
Apr 12, 2022
Assigned To Lie
Apr 7, 2022
Assigned To Lie
Apr 6, 2022
Teas Request For Reconsideration Received
Apr 6, 2022
Ex Parte Appeal-Instituted
Apr 6, 2022
Jurisdiction Restored To Examining Attorney
Apr 6, 2022
Exparte Appeal Received At Ttab
Oct 6, 2021
Notification Of Final Refusal Emailed
Oct 6, 2021
Final Refusal E-Mailed
Oct 6, 2021
Final Refusal Written
Aug 6, 2021
Teas/Email Correspondence Entered
Aug 5, 2021
Correspondence Received In Law Office
Aug 5, 2021
Teas Response To Office Action Received
Feb 6, 2021
Notification Of Non-Final Action E-Mailed
Feb 6, 2021
Non-Final Action E-Mailed
Feb 6, 2021
Non-Final Action Written
Feb 2, 2021
Assigned To Examiner
Jan 7, 2021
Notice Of Design Search Code E-Mailed
Jan 6, 2021
New Application Office Supplied Data Entered
Nov 9, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24